Silexion Therapeutics Corp (SLXNW)
2025-06-30 | ||||
|---|---|---|---|---|
| Income taxes | 3 | |||
| Total | 1,018 | |||
| Total | 1,266 | |||
| Total operating expenses | 2,284 | |||
| Operating loss | -2,284 | |||
| Financial expenses | 216 | |||
| Loss before income tax | -2,500 | |||
| Net loss | -2,503 | |||
| Net loss per share attributable to ordinary shareholders, basic (in dollars per share) | 4.32 | |||
| Net loss per share attributable to ordinary shareholders, diluted (in dollars per share) | 4.32 | |||
| Weighted average number of ordinary shares outstanding used in computation of diluted loss per share | 579,523 | |||
| Weighted average number of shares outstanding, basic | 579,523 | |||